Nano-X Imaging Ltd, a digital-imaging device maker for medical purposes, has filed Amendment No1 to Form F-1 Registration Statement on August 14, 2020 with the U.S Securities and Exchange Commission to announce terms for its IPO.
The company plans to raise $100 million by offering 5.9 million shares at a price range of $16 to $18. Assuming a successful IPO at the midpoint of the proposed range, the company expects a market capitalization of $793 million.
The company designed Nanox System to enable medical screening to improve accessibility and affordability of early-detection services worldwide. It also developed prototype in both hardware and software.
The Neve Ilan, Israel-based company was founded in 2018. It plans to list on the Nasdaq Global Market under the symbol “NNOX.” Cantor Fitzgerald, Oppenheimer & Co., Berenberg and CIBC are underwriters of the IPO.
The company engages Skadden, Arps, Slate, Meagher & Flom LLP as US Securities Counsel, and PricewaterhouseCoopers International Limited as Independent Auditor.
#ipo #nasdaq #PwC #Nanox #heathcare #imagingdevice #technology
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected].